We are in an era of unprecedented medical innovation. Scientists are making remarkable progress to diagnose and treat diseases, bringing new hope to patients across the world. Unfortunately, these breakthroughs fail to reach everyone due to barriers to care.
At the Annual Meeting of the Global Chagas Disease Coalition in Barcelona, Spain, Novartis announced that it is joining the Coalition as a member contributor. In addition, the company announced its commitment to launch a multinational, prospective, randomized study with heart failure drug, Entresto® (sacubitril / valsartan), in people with chronic Chagas cardiomyopathy, one form of heart failure with reduced ejection fraction. This is the first definitive morbidity and mortality study to assess a potential therapy for cardiac disease in this underserved patient population.
After one year implementing the strategies they learned at the 2017 Charles Schwab Pro Bono Challenge, the Sustainable Food Center is reporting some big impact. Its Farmers’ Market WIC program has grown three-fold. The organization has even brought on another staff member to manage the expanding program
Three years ago, Aramark teamed up with the American Heart Association as part of an innovative initiative called Healthy for Life® 20 By 20. The combined goal: To improve the health of Americans 20 percent by the end of 2020.
Coca‑Cola European Partners (CCEP) set out its sustainability performance in its 2018 integrated report, published today. CCEP increased the amount of recycled PET it used in 2018, while also increasing the amount of its packaging that is recyclable and reducing the amount of sugar in its products.
HP is partnering with Firsthand Technology, a VR healthcare company, to equip healthcare centers like Providence with new innovations for helping patients with pain management. Through the use of therapeutic games, VR is helping doctors and patients like Honjas think about and treat pain in new ways.
Taking home yet another major award for technology, innovation and corporate responsibility, Aflac today announced the My Special Aflac Duck, an innovative robotic duck that helps children cope with cancer, is the winner of this year’s top Award at SXSW in the Robotics and Hardware category. The prestigious SXSW award is added to a growing list of awards, which includes Engaget’s Best in Show Award at the 2018 Consumer Electronics Show and Time Magazine’s recognition as one of the 50 Best inventions for 2018.
At Pfizer, we believe that empowered women help build stronger communities. Fundamental to this belief is ensuring access to resources that allow women to make decisions about the health of themselves and their families.
A few Arkansas Children’s team members met with our local Aflac representative, Melanie Reynolds, and she gave a demonstration on the My Special Aflac Duck. These interactive robotic ducks are available complimentary to any of our patients that are undergoing cancer treatment. The duck provides companionship and acts as a toy, robot and medical device. The My Aflac Duck is a unique way to helps kids cope with the difficulties of undergoing treatment and elevates the patient experience. It brings joy to our patients and provides each child a sense of control by allowing them to be the caretaker of the duck while being treated. The duck communicates based on the child’s mood, and dances, nuzzles and cuddles accommodating the emotional needs of the child in real time.
Corporate governance, risk management, operational integrity, and regulatory compliance are demanding challenges that companies face in today’s ever...
Whirlpool Corporation has several CSR partners including United Way, Habitat for Humanity International, Boys & Girls Clubs of America and Consulada...
At Marathon Petroleum, our professional truck drivers share one common vision: no accidents, no injuries, and no harm to the environment. We’re proud...
In states where Key has a presence, there are approximately 1.7 million low- to moderate-income (LMI) households. Many LMI individuals don’t have bank...
